Peptilogics

Pittsburgh, PA · Founded 2013 · Privately Held (backing)

Developer of a therapeutic and drug discovery peptide platform designed to treat multidrug-resistant bacterial infections. Peptilogics is based in Pittsburgh, PA and was founded in 2013. It was valued at $150 million at its later-stage round in May 2025, the last priced event on record. It has raised $195 million across 4 recorded rounds; the latest was a $35.8 million early-stage round in Dec 2020.

PMV mark · valuation
$150.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$194.8M
Last round
Early Stage VC
Dec 2020

Who backs Peptilogics?

30 investors
InvestorType
GaingelsVenture capital
Founders FundVenture capital
Innovation WorksVenture capital
Alpha Wave GlobalGrowth equity
Peter ThielHigh net worth
CARB-XOther
Thiel CapitalFamily office
AAF ManagementOther
Bright Success CapitalFamily office
AMR Action Fund—
+ 20 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Peptilogics investors

30 investors are on record for Peptilogics, including Gaingels, Founders Fund, Innovation Works and Alpha Wave Global. By type, the record holds 3 venture capital firms and 2 family offices. The early-stage round in Dec 2020 drew 19 investors.

Free account
More of Peptilogics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Peptilogics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like Peptilogics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View